Migraine revolution and sumatriptan.
Palmer
J B
JB
Salonen
R
R
D002214:Capsules; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D008881:Migraine Disorders / Q000188:drug therapy*; D011759:Pyrrolidines / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D018170:Sumatriptan / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013810:Therapeutic Equivalency; D014363:Tryptamines
D002214:Capsules; D007211:Indoles; D011759:Pyrrolidines; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; C115647:eletriptan; D018170:Sumatriptan